Austedo® xr (deutetrabenazine) extended-release tablets, new once-daily formulation of austedo®, now available in the u.s.

Tel aviv, israel & parsippany, n.j.--(business wire)--teva pharmaceuticals, a u.s. affiliate of teva pharmaceutical industries ltd. (nyse and tase: teva), today announced that once-daily austedo xr (deutetrabenazine) extended-release tablets are now available for adults in the united states in 6 mg, 12 mg and 24 mg tablet strengths. austedo xr was recently approved by the u.s. food and drug administration (fda) for adults living with tardive dyskinesia (td) and chorea associated with huntington.
TEVA Ratings Summary
TEVA Quant Ranking